Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Incidence of Colorectal Cancer in Iran: A Systematic Review and Meta‑Analysis Publisher



Rahimi F1 ; Rezayatmand R1 ; Tabesh E2 ; Tohidinik HR3 ; Hemami MR4 ; Ravankhah Z5 ; Adibi P2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Centre for Academic Child Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  4. 4. Perspectum Ltd, Oxford, United Kingdom
  5. 5. Cancer Registry of Health Deputy, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2024


Abstract

Background: The incidence of colorectal cancer (CRC) is rising in Iran, but reports vary across different regions due to diverse methods and data sources. This study aimed to conduct a systematic review and meta analysis to provide an overview of the incidence rate of CRC and its trend among Iranians in various provinces. Materials and Methods: A comprehensive literature search based on the Preferred Reporting Items for Systematic Reviews and Meta Analyses checklist was performed using national and international databases for papers published up to December 2023. CRC incidence rates were extracted from the numbers, crude rates, and age standardized rates (ASRs). A meta analysis was conducted to calculate the incidence rate and 95% confidence intervals (CIs) in subgroups of sex and province. Results: The initial database search retrieved 1287 papers, with 47 studies meeting the inclusion criteria after further screening. Overall, the trend of CRC incidence has been increasing, although a different pattern was observed in 2008. The pooled incidence rate of CRC was 8.46 (95% CI: 7.16–9.86) per 100,000 population before the publication of the annual continuous reports of the Iranian National Cancer Registry. The latest national data (2014–2017) indicated an ASR of approximately 15 per 100,000 population. Conclusion: The incidence of CRC in Iran is lower than the global average. However, inconsistent cancer registration policies and gaps in registration have hindered the ability to establish a reliable trend of CRC incidence over time. © 2024 Journal of Research in Medical Sciences.
Other Related Docs
15. Epidemiology and Trend of Cancer in Isfahan 2005-2010, Journal of Research in Medical Sciences (2011)
20. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran, Asian Pacific Journal of Cancer Prevention (2015)
28. Survival of Rectal Cancer in Yazd, Iran, Asian Pacific Journal of Cancer Prevention (2014)
33. Economic Burden of Colorectal Cancer: A Scoping Review, Journal of Payavard Salamat (2023)
35. Familial Colorectal Cancertype X in Central Iran: A New Clinicopathologic Description, International Journal of Hematology-Oncology and Stem Cell Research (2017)
36. The Most Common Cancers in Iranian Women, Iranian Journal of Public Health (2009)
43. Effects of Physical Activity on Risk of Colorectal Cancer: A Case-Control Study, International Journal of Preventive Medicine (2016)
46. Prevalence of Stomach Cancer in Isfahan Province, Iran, The Gulf journal of oncology (2018)
49. The Epidemiology of Skin Cancer and Its Trend in Iran, International Journal of Preventive Medicine (2015)